Elevated concentrations of terfenadine, whether due to terfenadine overdose, significant impairment of hepatic function or concomitant administration of inhibitors of CYP3A4, may cause QT interval prolongation with risk of life-threatening ventricular tachyarrhythmias (such as severe ventricular tachycardia, torsades de pointes, and ventricular fibrillation).